Neurologic Imaging

What Is the Best Initial Imaging Study for Primary Hyperparathyroidism?

·
What Is the Best Initial Imaging Study for Primary Hyperparathyroidism?

A 58-year-old patient presents for a follow-up on routine lab work, which reveals persistent hypercalcemia. Subsequent testing confirms an elevated parathyroid hormone (PTH) level, establishing a biochemical diagnosis of primary hyperparathyroidism. You are now planning the preoperative workup before referring them to an endocrine surgeon. The critical question is which imaging study to order first to localize the presumed parathyroid adenoma and facilitate a minimally invasive surgical approach. This article provides a detailed clinical workflow for this exact scenario, focusing on the initial, preoperative localization of a parathyroid adenoma. According to the American College of Radiology (ACR) Appropriateness Criteria, a dedicated `US parathyroid` is a cornerstone of this workup and is rated Usually Appropriate.

Who Fits This Clinical Scenario?

This guidance applies to both adult and pediatric patients with a new, biochemically confirmed diagnosis of primary hyperparathyroidism (PHPT) who have not had prior neck surgery for this condition. The key inclusion criterion is the established biochemical diagnosis—typically elevated serum calcium with a non-suppressed or frankly elevated PTH level. The purpose of imaging in this context is not to make the diagnosis, but to localize the source of PTH overproduction to guide surgical planning.

It is crucial to distinguish this initial workup from other clinical situations. This workflow does not apply to patients with:

  • Recurrent or Persistent Hyperparathyroidism: Patients who have already undergone parathyroid surgery but remain hypercalcemic require a different imaging strategy, as scar tissue and altered anatomy complicate the search for missed or ectopic glands.
  • Secondary Hyperparathyroidism: This condition, most often seen in patients with chronic kidney disease, involves diffuse hyperplasia of all four parathyroid glands due to external stimuli (like low calcium or high phosphorus). Imaging for localization is generally not indicated as the treatment is typically medical management or subtotal parathyroidectomy.
  • Tertiary Hyperparathyroidism: This occurs when hyperplastic glands in long-standing secondary hyperparathyroidism become autonomous. While surgery may be indicated, the imaging and surgical approach differ from that of a single adenoma in PHPT.

What Diagnoses Are You Working Up in This Scenario?

When ordering initial imaging for primary hyperparathyroidism, the primary goal is to localize the anatomical source of hormone overproduction. The differential diagnosis for the underlying pathology is relatively narrow, but the anatomical location can vary significantly.

Single Parathyroid Adenoma: This is, by far, the most common cause of primary hyperparathyroidism, accounting for 80-85% of cases. A benign, solitary tumor in one of the four parathyroid glands secretes excess PTH. These are typically found in the neck, adjacent to the thyroid gland, but can be located ectopically in the mediastinum, within the thyroid, or elsewhere in the neck. Imaging is focused on identifying this single culprit gland.

Multiglandular Disease or Hyperplasia: In about 15-20% of cases, multiple parathyroid glands are abnormal. This can involve two adenomas (double adenoma) or diffuse hyperplasia of three or all four glands. Identifying this possibility preoperatively is critical, as it changes the surgical plan from a focused, minimally invasive parathyroidectomy to a more extensive bilateral neck exploration.

Parathyroid Carcinoma: This is an exceedingly rare cause of PHPT, representing less than 1% of cases. It often presents with more severe hypercalcemia and markedly elevated PTH levels. While imaging features can sometimes suggest malignancy (e.g., local invasion, large size), it is often indistinguishable from a benign adenoma on preoperative studies. The definitive diagnosis is made on pathology after surgical resection.

Why Is Parathyroid Ultrasound the Recommended Initial Study?

For the initial localization of a parathyroid adenoma in a patient with primary hyperparathyroidism, the ACR rates `US parathyroid` as Usually Appropriate. This recommendation is based on its excellent safety profile, accessibility, and diagnostic utility in this specific clinical context.

The primary strength of ultrasound is its high spatial resolution for evaluating structures in the neck. It can readily identify an enlarged parathyroid gland, which typically appears as a discrete, oval, hypoechoic solid mass posterior to the thyroid. A key advantage is the complete lack of ionizing radiation (adult and pediatric radiation relative level: O 0 mSv), making it an ideal first-line test. Furthermore, it is non-invasive, does not require IV contrast, and is widely available and less costly than other modalities.

However, several other studies are also rated Usually Appropriate, and it’s important to understand their roles:

  • Sestamibi Scans: Nuclear medicine studies like `Sestamibi dual-phase scan with SPECT or SPECT/CT neck` are also Usually Appropriate. These are functional studies that show areas of increased metabolic activity characteristic of parathyroid tissue. They are particularly valuable for detecting ectopic adenomas (e.g., in the chest) that are outside the field of view of a standard neck ultrasound. The trade-off is the use of ionizing radiation (adult RRL: ☢☢☢ 1-10 mSv). Many centers use both ultrasound and sestamibi preoperatively to maximize localization accuracy.
  • CT Neck: A `CT neck without and with IV contrast` is also rated Usually Appropriate. The key is the multiphase technique, often called a “4D-CT,” which assesses the characteristic rapid arterial enhancement and venous washout of an adenoma. It provides excellent anatomical detail but involves significant radiation (adult RRL: ☢☢☢ 1-10 mSv). In contrast, a `CT neck without IV contrast` is considered Usually not appropriate because adenomas are often isoattenuating to surrounding tissue and can be easily missed without contrast.

The recommendation for ultrasound first is a pragmatic one. It is highly effective for identifying adenomas in their typical location, avoids radiation, and is cost-effective. If it successfully localizes a candidate lesion, the workup may be complete. If it is negative or equivocal, a functional study like a sestamibi scan is an excellent next step.

What’s Next After Parathyroid Ultrasound? Downstream Workflow

The results of the initial parathyroid ultrasound directly guide the subsequent clinical and surgical pathway. The goal is to move from a biochemical diagnosis to a confident anatomical localization that enables a focused, successful operation.

If the ultrasound is positive and localizing: When the ultrasound clearly identifies a single enlarged parathyroid gland consistent with an adenoma, and this finding correlates with the patient’s anatomy (e.g., a right inferior parathyroid adenoma), the patient can be referred directly for a minimally invasive parathyroidectomy. The surgeon uses the imaging to plan a small, targeted incision, leading to shorter operative times and quicker recovery.

If the ultrasound is negative or equivocal: A negative ultrasound does not mean an adenoma isn’t present; it may be small, in an unusual location (ectopic), or obscured by overlying thyroid tissue or patient body habitus. In this common scenario, the next step is typically a functional imaging study. A `Sestamibi dual-phase scan with SPECT or SPECT/CT neck` is an excellent choice, as it is also rated Usually Appropriate and excels at finding ectopic glands in the mediastinum or elsewhere that ultrasound cannot visualize. The fusion SPECT/CT images provide both functional and precise anatomical information.

If the ultrasound suggests multiglandular disease: If the sonographer identifies more than one enlarged gland, it raises suspicion for multiglandular disease or hyperplasia. This is a critical finding, as it often changes the surgical plan from a minimally invasive approach to a traditional bilateral neck exploration, where the surgeon must identify all four glands. A sestamibi scan may still be obtained to provide complementary functional information before this more extensive surgery.

Pitfalls to Avoid (and When to Get Help)

Navigating the initial imaging workup for primary hyperparathyroidism requires an awareness of several common pitfalls that can lead to diagnostic delays or suboptimal surgical planning.

  • Relying on imaging for diagnosis: Remember that primary hyperparathyroidism is a biochemical diagnosis. Imaging is for preoperative localization only. A negative imaging workup in a patient with clear biochemical evidence of the disease should not prevent a referral to an experienced endocrine surgeon.
  • Underestimating operator dependence: The quality of a parathyroid ultrasound is highly dependent on the skill and experience of the sonographer. If the clinical suspicion is high but a general ultrasound is negative, consider having the study repeated at a high-volume center with dedicated head and neck imagers.
  • Mistaking thyroid nodules for parathyroid adenomas: Thyroid nodules are extremely common and can mimic the appearance of a parathyroid adenoma. Correlating with a sestamibi scan or, in some cases, fine-needle aspiration with PTH washout can help differentiate them.
  • Forgetting about ectopic glands: Approximately 15-20% of adenomas are in ectopic locations. A negative neck ultrasound should immediately prompt consideration of an imaging modality that can visualize the mediastinum, such as a sestamibi scan or 4D-CT.

If initial non-invasive imaging (ultrasound and/or sestamibi) is negative or conflicting, it is time to escalate. The patient should be referred to a high-volume endocrine surgeon who can determine if proceeding to surgery without definitive localization is appropriate or if more advanced imaging is warranted.

Related ACR Topics and Tools

For a comprehensive overview of imaging across all clinical variants of this condition, please consult our parent topic guide. For further exploration of adjacent scenarios or imaging techniques, the following GigHz resources are available to support your clinical decision-making.

Frequently Asked Questions

Is preoperative imaging always required for primary hyperparathyroidism?

While an experienced endocrine surgeon can perform a traditional four-gland exploration without preoperative imaging, localization studies are standard practice. A positive study allows for a minimally invasive parathyroidectomy, which has lower morbidity and shorter recovery time. A negative study prepares the surgeon for a more extensive exploration.

What if the ultrasound is negative but the sestamibi scan is positive?

This is a common and helpful scenario. The sestamibi scan is particularly good at identifying ectopic adenomas (e.g., in the chest) or glands that are difficult to see on ultrasound. A positive, localizing sestamibi scan is often sufficient for surgical planning, even with a negative ultrasound.

Why not just order a 4D-CT scan first, since it provides such great anatomical detail?

While 4D-CT is highly sensitive and specific, it involves a significant dose of ionizing radiation and requires IV contrast. The ACR recommends a stepwise approach, starting with non-radiation modalities like ultrasound first. 4D-CT is often reserved for cases where ultrasound and sestamibi scans are negative or discordant, or in the setting of re-operative surgery.

Does this imaging guidance apply to children with primary hyperparathyroidism?

Yes, this ACR scenario explicitly includes both adults and children. The principle of starting with a non-radiation modality like ultrasound is even more critical in pediatric patients to minimize cumulative radiation exposure over their lifetime. The relative radiation level for ultrasound is O 0 mSv for all age groups.

Can an intrathyroidal parathyroid adenoma be seen on ultrasound?

Yes, an adenoma located within the thyroid gland can be visualized on ultrasound, though it can be challenging to distinguish from a primary thyroid nodule. In these cases, a sestamibi scan can be very helpful, as the lesion will show radiotracer uptake while most thyroid nodules will not. Fine-needle aspiration with PTH level measurement from the washout fluid can also confirm the diagnosis.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 29, 2026